2013
DOI: 10.3998/ark.5550190.p008.395
|View full text |Cite
|
Sign up to set email alerts
|

Stereoselective synthesis and sialidase inhibition properties of KDO-based glycosyloxathiins

Abstract: The stereoselective synthesis of KDO-based glyco-1,4-oxathiins is described. Relying on a totally diastereoselective inverse electron demand hetero Diels-Alder, αα′-dioxothiones as electron-poor heterodienes, and glycals as electron-rich dienophiles, reacted to give, in high yield, the KDO-based glyco derivatives 11 and 12a-c. Taking into account their structural features, biological tests have been run to evaluate the properties of 11 and 12a as sialidase inhibitors. The synthetic and biological data reporte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…compounds 1 – 4 , Figure 1). [13] The molecular mimicry properties of these molecules allowed for the investigation of the biological effect that these glycomimetics had in specific contexts where the recognition of carbohydrates plays a crucial role leading to the identification of antibacterial agents [13a,14] (compound 1 , Figure 1) inhibitors of glycosyltransferases [15] and glycosidases [13b] (compounds 1 – 2 , Figure 1), and tumor associated carbohydrate antigens [16–19] (compounds 3 – 4 , Figure 1).…”
Section: Introductionmentioning
confidence: 99%
“…compounds 1 – 4 , Figure 1). [13] The molecular mimicry properties of these molecules allowed for the investigation of the biological effect that these glycomimetics had in specific contexts where the recognition of carbohydrates plays a crucial role leading to the identification of antibacterial agents [13a,14] (compound 1 , Figure 1) inhibitors of glycosyltransferases [15] and glycosidases [13b] (compounds 1 – 2 , Figure 1), and tumor associated carbohydrate antigens [16–19] (compounds 3 – 4 , Figure 1).…”
Section: Introductionmentioning
confidence: 99%